Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

Similar articles for PubMed (Select 23136255)

1.

High-sensitivity C-reactive protein levels and cancer mortality.

Ko YJ, Kwon YM, Kim KH, Choi HC, Chun SH, Yoon HJ, Goh E, Cho B, Park M.

Cancer Epidemiol Biomarkers Prev. 2012 Nov;21(11):2076-86. doi: 10.1158/1055-9965.EPI-12-0611.

2.

High-sensitivity C-reactive protein and cancer.

Lee S, Choe JW, Kim HK, Sung J.

J Epidemiol. 2011;21(3):161-8. Epub 2011 Feb 26.

3.

CRP level and HDL cholesterol concentration jointly predict mortality in a Korean population.

Kim KI, Oh SW, Ahn S, Heo NJ, Kim S, Chin HJ, Na KY, Chae DW, Kim CH, Kim S.

Am J Med. 2012 Aug;125(8):787-95.e4. doi: 10.1016/j.amjmed.2012.02.013.

PMID:
22840665
4.

Effects of statin therapy according to plasma high-sensitivity C-reactive protein concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): a retrospective analysis.

McMurray JJ, Kjekshus J, Gullestad L, Dunselman P, Hjalmarson A, Wedel H, Lindberg M, Waagstein F, Grande P, Hradec J, Kamenský G, Korewicki J, Kuusi T, Mach F, Ranjith N, Wikstrand J; CORONA Study Group.

Circulation. 2009 Dec 1;120(22):2188-96. doi: 10.1161/CIRCULATIONAHA.109.849117. Epub 2009 Nov 16. Erratum in: Circulation. 2010 Jun 29;121(25):e461.

5.
6.

C-reactive protein predicts future cardiovascular events in patients with carotid stenosis.

Schlager O, Exner M, Mlekusch W, Sabeti S, Amighi J, Dick P, Wagner O, Koppensteiner R, Minar E, Schillinger M.

Stroke. 2007 Apr;38(4):1263-8. Epub 2007 Feb 22.

7.

C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.

Siemes C, Visser LE, Coebergh JW, Splinter TA, Witteman JC, Uitterlinden AG, Hofman A, Pols HA, Stricker BH.

J Clin Oncol. 2006 Nov 20;24(33):5216-22.

8.

Serum high sensitivity C-reactive protein and cognitive function in elderly women.

Komulainen P, Lakka TA, Kivipelto M, Hassinen M, Penttilä IM, Helkala EL, Gylling H, Nissinen A, Rauramaa R.

Age Ageing. 2007 Jul;36(4):443-8. Epub 2007 May 30.

9.

Elevated high-sensitivity C-reactive protein, a marker of advanced stage gastric cancer and postgastrectomy disease recurrence.

Woo Y, Hyung WJ, Obama K, Kim HI, Pak KH, Son T, Noh SH.

J Surg Oncol. 2012 Mar 15;105(4):405-9. doi: 10.1002/jso.22129. Epub 2011 Oct 24.

PMID:
22025360
10.

Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.

Bonnet J, McPherson R, Tedgui A, Simoneau D, Nozza A, Martineau P, Davignon J; CAP Investigators.

Clin Ther. 2008 Dec;30(12):2298-313. doi: 10.1016/j.clinthera.2008.12.023.

PMID:
19167589
11.

High-sensitivity C-reactive protein is a strong risk factor for death after acute ischemic stroke among Chinese.

Huang Y, Jing J, Zhao XQ, Wang CX, Wang YL, Liu GF, Wang CJ, Liu LP, Yang XM, Jiao Y, Jiao Y, Wang LS, Wang YJ, Gu WK.

CNS Neurosci Ther. 2012 Mar;18(3):261-6. doi: 10.1111/j.1755-5949.2012.00296.x.

PMID:
22449109
12.

C-reactive protein levels are not associated with increased risk for colorectal cancer in women.

Zhang SM, Buring JE, Lee IM, Cook NR, Ridker PM.

Ann Intern Med. 2005 Mar 15;142(6):425-32.

PMID:
15767620
13.

Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer.

Allin KH, Nordestgaard BG.

Crit Rev Clin Lab Sci. 2011 Jul-Aug;48(4):155-70. doi: 10.3109/10408363.2011.599831. Review.

PMID:
22035340
14.

High-sensitivity C-reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohn's disease: a marker for patient classification?

Kiss LS, Papp M, Lovasz BD, Vegh Z, Golovics PA, Janka E, Varga E, Szathmari M, Lakatos PL.

Inflamm Bowel Dis. 2012 Sep;18(9):1647-54. doi: 10.1002/ibd.21933. Epub 2011 Nov 13.

PMID:
22081542
15.

Physical activity, high-sensitivity C-reactive protein, and total and cardiovascular disease mortality in type 2 diabetes.

Vepsäläinen T, Soinio M, Marniemi J, Lehto S, Juutilainen A, Laakso M, Rönnemaa T.

Diabetes Care. 2011 Jul;34(7):1492-6. doi: 10.2337/dc11-0469. Epub 2011 May 20.

16.

Markers of inflammation in relation to long-term cardiovascular mortality in patients with lower-extremity peripheral arterial disease.

Urbonaviciene G, Frystyk J, Flyvbjerg A, Urbonavicius S, Henneberg EW, Lindholt JS.

Int J Cardiol. 2012 Oct 4;160(2):89-94. doi: 10.1016/j.ijcard.2011.03.030. Epub 2011 Apr 3.

PMID:
21463908
17.

Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study.

Allin KH, Nordestgaard BG, Flyger H, Bojesen SE.

Breast Cancer Res. 2011 Jun 3;13(3):R55. doi: 10.1186/bcr2891.

18.

[Association between high sensitivity C-reactive protein levels in serum and the 5-year-accumulative-risk of diabetes].

Liu HH, Zhao D, Wang W, Qin LP, Liu J, Sun JY, Wang M, Li Y, Qi Y, Liu J.

Zhonghua Liu Xing Bing Xue Za Zhi. 2011 Jan;32(1):1-4. Chinese.

PMID:
21518530
19.

A J-shaped association between high-sensitivity C-reactive protein and mortality in kidney transplant recipients.

Winkelmayer WC, Schaeffner ES, Chandraker A, Kramar R, Rumpold H, Sunder-Plassmann G, Födinger M.

Transpl Int. 2007 Jun;20(6):505-11. Epub 2007 Mar 16.

PMID:
17362474
20.

Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.

Sabatine MS, Morrow DA, Jablonski KA, Rice MM, Warnica JW, Domanski MJ, Hsia J, Gersh BJ, Rifai N, Ridker PM, Pfeffer MA, Braunwald E; PEACE Investigators.

Circulation. 2007 Mar 27;115(12):1528-36. Epub 2007 Mar 19.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk